Parents mull class suit vs Sanofi over Dengvaxia mess

An Aedes Aegypti mosquito, said to be the carrier of  the dengue virus, is photographed on human skin in a lab of the International Training and Medical Research Training Center (CIDEIM) on January 25, 2016, in Cali, Colombia. /AFP/Luis Robayo/


QUEZON CITY, Philippines (Eagle News) — Several parents are considering filing a class suit against French drug manufacturer Sanofi Pasteur.

This, after the pharmaceutical giant admitted that its dengue vaccine, Dengvaxia, could cause “severe cases” in those who were administered the  substance but who were not afflicted with the disease beforehand.

Atty. Ernesto Francisco, a representative of several of the parents,  said a class suit would ensure the existence of funds which could be used to cover the medical expenses of those who could suffer the adverse effects of the vaccine.

In a radio interview, Nelson de Guzman, father of Kristine Mae who died six months after she was administered the vaccine under the former President Benigno Aquino III’s administration’s vaccination program, said he was determined to hold the pharmaceutical firm accountable.

De Guzman said she was ten years old at that time.

“Siguro kung hindi namin siya pinabakunahan doon, buhay pa siya ngayon,” he said.